Mindfulness Meditation Intervention for Colorectal Cancer Patients and Caregivers

Colorectal Cancer Clinical Trial

— Mindfulness  

Official title:

Being Present: Audio-Based Mindfulness Meditation Intervention for Colorectal Cancer Patients and Caregivers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02423720
• Other study ID #: 15455
• Status: Completed
• Phase: N/A
• First received: April 17, 2015
• Last updated: February 22, 2018
• Start date: April 28, 2015
• Est. completion date: January 1, 2017

Study information

• Verified date: February 2018
• Source: University of California, San Francisco
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a audio based mindfulness meditation intervention for colorectal cancer patients and caregivers. A 8-week single arm study will be conducted among University of California, San Francisco (UCSF) patients with metastatic colorectal cancer undergoing chemotherapy and caregivers of these patients (44 participants total).

Description:

A metastatic cancer diagnosis is associated with high levels of distress in both patients and caregivers. The investigators hypothesize that an audio-based mindfulness intervention will be an effective means to reduce distress and improve quality of life among patients with advanced cancer and their caregivers. With the Being Present study, conduct an 8-week single arm study among UCSF patients with metastatic colorectal cancer undergoing chemotherapy and caregivers of these patients (44 participants total). Participants will receive an informational booklet containing a practice log and a MP3 player containing an introductory lecture and guided meditations. Practice reminders will be sent via text messages. Emails will contain practice assignments and links to validated survey instruments. The survey instruments (National Comprehensive Cancer Network (NCCN) Distress Thermometer and National Institutes of Health (NIH) Patient Reported Outcomes Measurement Information System (PROMIS) adult short forms) will measure global health, anxiety, depression, fatigue, and sleep quality before, during, and after the intervention to obtain preliminary estimates of the efficacy of the intervention among patients and caregivers on self-reported outcomes. Qualitative data will be collected from pre- and post-intervention interviews.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 53
• Est. completion date: January 1, 2017
• Est. primary completion date: May 3, 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Eligible patients must:

• Carry a diagnosis of metastatic colon, rectum, or small bowel adenocarcinoma

• Anticipate receiving chemotherapy for at least 12 weeks total from the time of recruitment

• Have life expectancy of at least 6 months

• Have Karnofsky Performance Status =60

• Be able to speak and read English

• Have access to a mobile phone

• Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet

• Have a distress level of =3 on the NCCN Distress Thermometer (DT).[1, 40]

• An effort will always be made to recruit patient and caregiver pairs, but unpaired patients are also eligible

Eligible caregivers are a spouse/partner, other family member, or a close friend of a patient with metastatic colon, rectum, or small bowel adenocarcinoma.

Eligible caregivers must:

• Be able to speak and read English

• Have access to a mobile phone

• Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet

Exclusion Criteria:

This study is limited the study to patients with metastatic colon, rectum, or small bowel adenocarcinoma, because treatment regimens and disease trajectories for these disease groups are similar.

Deafness, Current meditation practice (>2 episodes or >1 hour total, weekly), and current enrollment in a stress reduction program are exclusion criteria for the intervention study because the study is designed as an audio-based introduction to mindfulness meditation.

Patients with a DT level >7 will be considered on a case-by- case basis. Patients and caregivers who participate in a focus group and meet criteria for the intervention will be given the opportunity to participate: data will be collected, but these patients/participants will not be included in the final analyses so as not to bias the results.

Related Conditions & MeSH terms

• Colorectal Cancer
• Colorectal Neoplasms

Intervention

Behavioral:
• Audio-Based Mindfulness
Audio-based mindfulness tracks (MP3 format).

Locations

Country	Name	City	State
United States	University of California San Francisco	San Francisco	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, San Francisco

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Quality of life, as assessed by NIH PROMIS instruments at the beginning, midpoint and end of the study		0, 4 and 8 weeks
Other	Distress, as assessed by NCCN Distress Thermometer and NIH PROMIS instruments at the beginning, midpoint and end of the study		0, 4 and 8 weeks
Other	Anxiety, as assessed by NCCN Distress Thermometer and NIH PROMIS instruments at the beginning, midpoint and end of the study		0, 4 and 8 weeks
Other	Depression, as assessed by NCCN Distress Thermometer and NIH PROMIS instruments at the beginning, midpoint and end of the study		0, 4 and 8 weeks
Other	Fatigue, as assessed by NCCN Distress Thermometer and NIH PROMIS instruments at the beginning, midpoint and end of the study		0, 4 and 8 weeks
Other	Sleep quality, as assessed by NCCN Distress Thermometer and NIH PROMIS instruments at the beginning, midpoint and end of the study		0, 4 and 8 weeks
Primary	Proportion of eligible patients and caregivers who agree to be screened, consent to participate, and complete or partially complete the intervention, as a measure of feasibility and acceptability.		8 weeks
Primary	Adherence to the intervention, as assessed by frequency and duration of practicing the exercises (recorded in a log and responses to text messages)		8 weeks
Secondary	Reasons for ineligibility, as a measure of feasibility		8 weeks
Secondary	Proportion of enrolled patients and caregivers who refuse to participate in or complete the intervention, as a measure of feasibility and acceptability		8 weeks
Secondary	Reasons for non-participation/non-continuation of the intervention, as a measure of feasibility and acceptability		8 weeks
Secondary	Adherence to the intervention, as assessed by frequency and duration of practicing the exercises (recorded in a log and responses to text messages)		8 weeks